相关实验视频

Updated: May 10, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

欧戈氨酸通过ROS-MAPK信号轴缓解骨质疏松症

Zhen Guo¹, Yiwen Huang², Xiaowei Wang²

¹Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 200072 Shanghai, PR China; School of Clinical Medicine, Jinggangshan University, 343009 Ji'an, Jiangxi, China.

|April 26, 2025

概括

欧戈氨酸 (EGT) 有效地抑制骨质细胞的形成,并减少骨质疏松症模型中的骨质损失. 这种抗氧化氨基酸减轻了活性氧物种 (ROS) 的积累,提供了潜在的新治疗策略.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
药理学药理学是指药理学的学科.

背景情况:

反应性氧物种 (ROS) 的积累影响骨质细胞功能,这是骨质疏松症的关键因素.
骨质疏松症的治疗需要准骨质细胞形成和ROS途径.
作为一种强有力的抗氧化剂的ergothioneine (EGT) 之前没有针对骨质疏松症进行研究.

研究的目的:

在体外和体内研究埃尔戈西欧内因 (EGT) 对骨质细胞形成的影响.
评估EGT作为治疗骨质疏松症的治疗剂的潜力.

主要方法:

在RANKL诱导的骨质细胞分化和体形成的体外研究.
在体内研究使用卵巢切除 (OVX) 的小鼠模型.
评估细胞内ROS水平,抗氧化酶表达 (HO-1,catalase),MAPK信号通路和骨质细胞特异性蛋白质表达 (Trap,c-Fos,Ctsk).
微型CT成像和组织学分析用于骨损失的评估.

主要成果:

在体外,EGT抑制了RANKL诱导的受体皮带形成和骨质细胞发育.
通过对HO-1和catalase进行上调,EGT降低了细胞内ROS.
通过MAPK路径减弱,EGT降低了Trap,c-Fos和Ctsk的表达.
在OVX小鼠中,EGT可以防止脊椎骨损失,这可能是由于骨质细胞数量减少.

结论:

欧戈氨酸 (EGT) 在抑制骨质细胞形成和减轻ROS积累方面显示出显著的潜力.
作为治疗骨质疏松症的新型治疗剂,EGT显示出前景.

关键词:

埃尔戈西奥尼因 (Ergothioneine) 是一种具有活力的物质.通过MAPK路径.骨质结晶体骨质结晶体是一个骨质疏松症是一种骨质疏松症.这就是ROSOS ROS.

更多相关视频

Osteoclast Derivation from Mouse Bone Marrow

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

相关概念视频

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...